Rate of Viral Evolution and Risk of Losing Future Drug Options in Heavily Pretreated, HIV-Infected Patients Who Continue to Receive a Stable, Partially Suppressive Treatment Regimen-Reference-Cited by-同舟云学术

Rate of Viral Evolution and Risk of Losing Future Drug Options in Heavily Pretreated, HIV-Infected Patients Who Continue to Receive a Stable, Partially Suppressive Treatment Regimen

Published:2006-11-15 Issue:10 Volume:43 Page:1329-1336
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Hatano H.,Hunt P.,Weidler J.,Coakley E.,Hoh R.,Liegler T.,Martin J. N.,Deeks S. G.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/43/10/1329/1386515/43-10-1329.pdf

Reference26 articles.

1. Treatment for Adult HIV Infection

2. Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus

3. Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy

4. HIV-1 Drug Resistance Evolution Among Patients on Potent Combination Antiretroviral Therapy With Detectable Viremia

5. Natural Variation of Drug Susceptibility in Wild-Type Human Immunodeficiency Virus Type 1

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

2. Treatment outcomes 12 months after antiretroviral therapy initiation in Oman: a nationwide study from the Middle East;AIDS Care;2021-10-26

3. Predictors of virologic failure among people living with HIV in Oman: a national study from the Middle East;International Journal of STD & AIDS;2020-12-18

4. Policy and practice suggestions to improve performance on the UNAIDS 90‐90‐90 targets: Results from a nominal group technique with HIV experts in Southwest Ethiopia;Health Expectations;2020-08-05

5. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015;HIV Medicine;2016-08